companydata.dkBKG-PHARMA ApS: Financial statements 2016
CVR: 27959350
BKG-PHARMA ApS (CVR 27959350) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity amounted to DKK -2,682,678.
- Gross Profit
- -616,406 kr.
- Profit/Loss
- -18,025,433 kr.
- Equity
- -2,682,678 kr.
- Total Assets
- 315,632 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -616 t. | -18 mio. | -2.7 mio. | - |
| 2015 | - | -715 t. | -95 t. | 15.3 mio. | - |
| 2014 | - | -28 t. | -65 t. | 14.5 mio. | - |
| 2013 | - | 938 t. | 792 t. | 14.5 mio. | - |
| 2012 | - | 837 t. | 535 t. | 13.8 mio. | - |
How creditworthy is BKG-PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
BKG-PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -715,177, and the net result was DKK -94,523.
About BKG-PHARMA ApS
BKG-PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2004 and dissolved in 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees. In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity amounted to DKK -2,682,678.